In line with the decreased cytotoxicity, proliferation rate of the cells and number of αSMA+ cells, which are hallmarks for pulmonary fibrosis were limited by FGF10-STAB2, whereas wildtype FGF10 showed no effect (Figs. 7C, D; S11A). This evidence concerns the gene FGF10 and pulmonary fibrosis.